Being a disease that affects the nervous system, the administration of a localized drug is not easy, and in this case, the authors were able to administer TPP1 effectively and cumulatively through sEV via intrathecal and intraperitoneal routes in the BD mouse model, observing a significant therapeutic effect [51]. Here, TPP1 is linked to Behcet disease.